Rain Oncology Inc
Change company Symbol lookup
Select an option...
RAIN Rain Oncology Inc
KGJI Kingold Jewelry Inc
PARA Paramount Global
TFINP Triumph Financial Inc
HWKN Hawkins Inc
COUP Coupa Software Inc
ACAZF Acadian Timber Corp
BSX Boston Scientific Corp
ACDVF Air Canada
DCFCW Tritium DCFC Equity Warrant Exp 13th Jan 2027 *W EXP 01/13/2027
Go

Health Care : Pharmaceuticals |
Company profile

Rain Oncology Inc., formerly Rain Therapeutics Inc., is a late-stage precision oncology company. The Company is focused on developing therapies that target oncogenic drivers to genetically select patients. The Company’s product candidates include milademetan and RAD52. Its milademetan is an oral small molecule, an inhibitor of mouse double minute 2 (MDM2) is being developed in patients with wildtype tumor protein 53 (p53) cancers that are also exhibiting MDM2 dependence. MDM2 dependence may be occurring either through MDM2 gene amplification, protein overexpression, loss of an MDM2 regulator, or other mechanisms. RAD52 is focused on the DNA Damage Response (DDR) pathway. RAD52 represents a strategy for patients that may exhibit homologous recombination deficiencies (HRD+), or a loss of function, of several pathway constituents, including BRCA1/2, PALB2, or several others in tumor types frequently characterized by these deficiencies.

Price
Delayed
$10.00
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 919 shares is on pace to be much lighter than RAIN's 10-day average volume of 261,802 shares.

919
  • Prev Close
    10.00
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    261.8K
  • Last (time)
    3:59p ET 01/26/23
  • Last (size)
    5
  • 52-Wk Range
    2.15 - 14.48
    LowHigh
  • (05/26/22 - 01/10/23)
    30.94%
  • 113.7%
  • Market Cap
    353.2M
  • Shares Outstanding
    35.1M
  • -2.68
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 74.98
  • (% of float 01/15/23)
    1.29

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.